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Patient- and Surgeon-Level Variation in Patient-Reported Sexual Function
Outcomes Following Radical Prostatectomy Over 2 Years
Results From a Statewide Surgical Improvement Collaborative
Nnenaya Agochukwu-Mmonu, MD, MS; Ji Qi, MS; Rodney L. Dunn, MS; James Montie, MD;
Daniela Wittmann, PhD, MSW; David Miller, MD, MPH; Rabia Martin, BS; Tae Kim, MHSA;
William K. Johnston III, MD; James Peabody, MD
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IMPORTANCE Of patient-reported outcomes for individuals undergoing radical
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prostatectomy, sexual function outcomes are among the most reported and the most
detrimental to quality of life. Understanding variations at the patient and surgeon level may
inform collaborative quality improvement.
OBJECTIVE To describe patient- and surgeon-level sexual function outcomes for patients

undergoing radical prostatectomy in the Michigan Urological Surgery Improvement
Collaborative (MUSIC) and to examine the correlation between surgeon case volume and
sexual function outcomes.
DESIGN, SETTING, AND PARTICIPANTS This is a prospective cohort study using the MUSIC
registry and patient-reported sexual function outcome data. Patient- and surgeon-level
variation in sexual function outcomes were examined among patients undergoing radical
prostatectomy from May 2014 to August 2019. Sexual function outcome data were collected
using validated questionnaires, which were completed before surgery and at 3, 6, 12, and 24
months’ follow-up following surgery. All participants were male. Race and ethnicity data were
self-reported and were included to examine potential variation in outcomes by race and/or
ethnicity. Data were analyzed from January 2021 to March 2021.
MAIN OUTCOMES AND MEASURES There were 4 outcomes in this study, including the 26-item
Expanded Prostate Cancer Index Composite (EPIC-26) sexual function scores at 3, 6, 12, and
24 months’ follow-up; patient-level sexual function recovery at 12- and 24-month follow-up;
surgeon-level variation in sexual function outcomes at 12- and 24-month follow-up; and
correlation between surgeon case volume and sexual function outcomes.
RESULTS A total of 1426 male patients met inclusion criteria for this study. The median (IQR)
age was 64 (58-68) years. A total of 115 participants (8%) were Black, 1197 (84%) were White,
25 (2%) were of another race or ethnicity (consolidated owing to low numbers), and 89 (6%)
were of unknown race or ethnicity. Among patients undergoing bilateral nerve-sparing radical
prostatectomy, mean (SD) EPIC-26 sexual function scores at 12- and 24-month follow-up (12
months, 39 [28]; 24 months, 63 [29]) did not return to baseline levels. There was wide
variation in EPIC-26 sexual function scores at both 12-month follow-up (range, 23-69;
P < .001) and 24-month follow-up (range, 27-64; P < .001). Similar variations were found in
EPIC-26 sexual function scores and recovery of sexual function by surgeon. Recovery rates
ranged from 0% to 40% of patients at 12-month follow-up (18 surgeons; P < .001) and 3% to
44% of patients at 24-month follow-up (12 surgeons; P < .001). Surgeon case volume and
sexual function outcomes were not significantly correlated. On multivariable analysis, the
following variables were associated with better recovery at 24-month follow-up: younger age
(P < .001), lower baseline EPIC-26 sexual function score (P < .001), lower Gleason score
(P = .05), and nonobesity (P = .03).
CONCLUSIONS AND RELEVANCE In this study, there was significant patient- and surgeon-level
variation in sexual function recovery over 2 years following radical prostatectomy. Variation in
surgeon-level sexual function outcomes presents an opportunity and model for surgical
collaborative quality improvement.

JAMA Surg. 2022;157(2):136-144. doi:10.1001/jamasurg.2021.6215
Published online December 1, 2021. Corrected on January 5, 2022.
136

Author Affiliations: Department of
Urology, New York University,
New York (Agochukwu-Mmonu);
Department of Population Health,
New York University, New York
(Agochukwu-Mmonu); Department
of Urology, University of Michigan,
Ann Arbor (Qi, Dunn, Montie,
Wittmann, Miller, Martin); Dow
Division of Health Services Research,
University of Michigan, Ann Arbor
(Qi, Dunn, Montie, Wittmann, Miller,
Martin); Department of Orthopedic
Surgery, University of Michigan, Ann
Arbor (Kim); Department of Urology,
Beaumont School of Medicine,
Oakland University, Auburn Hills,
Michigan (Johnston); Department of
Urology, Henry Ford Health System,
Detroit, Michigan (Peabody).
Corresponding Author: Nnenaya
Agochukwu-Mmonu, MD, MS,
Department of Urology, New York
University, 221 E 41st St, New York,
NY 10017 (nnenaya.mmonu@
nyulangone.org).
(Reprinted) jamasurgery.com

© 2021 American Medical Association. All rights reserved.

Downloaded From: https://jamanetwork.com/ by a Henry Ford Health System User on 02/15/2022

Patient- and Surgeon-Level Variation in Patient-Reported Sexual Function Outcomes Following Radical Prostatectomy

R

adical prostatectomy (RP) is the most frequently selected treatment choice for localized prostate cancer,1,2
yet has the potential to negatively affect sexual function, a key patient-reported outcome and integral component
of health-related quality of life.3 Population-based studies estimate that 78% to 87% of patients have erectile dysfunction following RP, an outcome associated with patient distress, dissatisfaction, and decision regret.4-6 Patient-reported sexual
function outcomes are indispensable in the provision of highquality care.7
Michigan Urological Surgery Improvement Collaborative
(MUSIC) Patient Reported Outcomes (PRO) assesses patient recovery following RP. Despite the fact that sexual function outcomes are an important measure of high-quality and highvalue care, little has been done to improve these outcomes
at the surgeon level. To date, to our knowledge, there are no
data on the association of surgeon characteristics with sexual
function outcomes among patients undergoing RP. However,
data on sexual function have facilitated patient counseling
and shared decision-making,8 and there remains an opportunity to examine methods to potentially improve these outcomes. Outcome variation at the surgeon level potentially introduces a modifiable process in the structure, process, and
outcome framework of health care quality.9 In this framework, structural measures impact process measures, which in
turn affect outcomes. For example, it is plausible that in a cohort of patients with favorable characteristics, 2 surgeons may
have varied sexual function outcomes attributable to surgeon technique and skill level. If this is recognized and examined, collaborative quality improvement may lead to improved sexual function outcomes and subsequently improved
patient satisfaction and less decision regret.
Herein, we describe sexual function recovery over 2 years
and examine patient- and surgeon-level variation in sexual
function recovery using data from MUSIC, a physician-led quality improvement collaborative established in 2011 in partnership with Blue Cross Blue Shield of Michigan.10 Our aim is to
provide insight into factors associated with patient-level sexual
function recovery with the potential for quality improvement to optimize sexual function outcomes after RP.

Methods
MUSIC comprises 46 diverse community and academic urology practices representing approximately 90% of the urologists in the state of Michigan. A key priority of MUSIC is to
improve patient-reported outcomes after RP through collaborative quality improvement. This objective led to the development of MUSIC-PRO, a statewide web-based system established in 2014 for measuring and improving outcomes and
health-related quality of life; data are collected at baseline (before RP) and 3, 6, 12, and 24 months’ follow-up following RP.11
Prior reports have described MUSIC’s data acquisition and quality control activities.12,13 Each MUSIC practice obtained an exemption or approval for collaborative participation from a local institutional review board, and informed consent was
waived as participation is voluntary. The cohort in this study
jamasurgery.com
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Key Points
Question Is there patient- and surgeon-level variation in
patient-reported sexual function outcomes following radical
prostatectomy?
Findings In this cohort study including 1426 male patients, there
was wide variation in patient-reported sexual function outcomes
at the patient and surgeon level, which persisted when controlling
for patient characteristics. There was no significant correlation
between surgeon case volume and sexual function outcomes.
Meaning Surgeon-level variation in sexual function outcomes
among patients undergoing radical prostatectomy may present an
opportunity for collaborative quality improvement.

included all men in the MUSIC registry who underwent RP from
May 2014 to August 2019 and enrolled in MUSIC-PRO. Data
were analyzed from January 2021 to March 2021.

Measures
The MUSIC-PRO survey administered from May 2014 to September 2016 used the Memorial Sloan Kettering Symptom Tracking and Reporting system. This system includes the International Index of Erectile Function 6 (IIEF-6)14 to measure sexual
function. The subsequent MUSIC-PRO survey administered from
September 2016 to the present uses the 26-item Expanded Prostate Cancer Index Composite (EPIC-26).15 The surveys were administered at baseline (prior to RP) and 3, 6, 12, and 24 months’
follow-up following RP. A crosswalk was used to convert the
IIEF-6 items to EPIC-26 domain scores.16
The IIEF-6 measures sexual function. Higher scores indicate better function. Patients who were not sexually active were
prompted to bypass the IIEF-6 and were not included in the
analyses. EPIC-26 domains include sexual (6 items), urinary
irritation or obstruction (4 items), urinary incontinence (4
items), bowel (6 items), and vitality or hormonal (5 items). Each
domain is scored from 0 to 100, with increasing scores representing better function. EPIC-26 was specifically designed for
measuring health-related quality of life for patients undergoing prostate cancer treatments. Clinical interpretation of the
EPIC-26 has been described.17
The MUSIC registry includes detailed clinical and demographic information, including patient age, race and ethnicity, prostate-specific antigen (PSA), comorbidities, Gleason
score, clinical or pathological T stage, body mass index (BMI;
calculated as weight in kilograms divided by height in meters
squared), nerve sparing (none, unilateral, and bilateral), surgeon, and MUSIC-PRO survey responses.

Outcomes
Four outcomes were examined in this study: mean EPIC-26
sexual domain scores at 3, 6, 12 and 24 months’ follow-up;
sexual function recovery at 12- and 24-month follow-up; surgeon-level variation in sexual function at 12- and 24-month follow-up; and correlation between surgeon case volume and
sexual function outcomes. Sexual function recovery was defined as recovery of 90% or more of baseline EPIC-26 sexual
domain score at each time point.
(Reprinted) JAMA Surgery February 2022 Volume 157, Number 2
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Statistical Analyses
EPIC-26 Sexual Domain Scores
Mean EPIC-26 sexual domain scores at each time (baseline
and 3, 6, 12, and 24 months’ follow-up) were summarized
and stratified by nerve-sparing status (none, unilateral, and
bilateral). Among patients with both baseline and 24-month
PRO data, clinical and demographic characteristics were
summarized using appropriate tests. The proportion of
patients achieving sexual function recovery at 12- and
24-month follow-up was compared across different patient
subgroups using χ2 test.
Multivariable Model
To assess independent associations between patient-level factors and sexual function recovery, a mixed-effects logistic regression model was performed. The model included patient
demographic characteristics (age and race and ethnicity), clinical characteristics (BMI and diabetes status), baseline EPIC-26
urinary and sexual function score, tumor characteristics (pros-

Table 1. Clinical and Demographic Characteristics of Study Sample
Characteristic

No. (%)

Age, median (IQR), y

64 (58-68)

BMI, median (IQR)a

28 (26-32)

Marital status
Married/in relationship/dating

1146 (90)

Single/divorced/widowed

129 (10)

Surgeon-Level Analysis
Surgeon-level variation in EPIC-26 sexual domain score and
sexual function recovery was assessed. To reduce betweensurgeon variability as a result of patient case mix, only men
who underwent bilateral nerve-sparing RP and had a baseline
EPIC-26 sexual domain score of 73 or higher were included for
this analysis, with the cutoff selected a priori based on published definitions of potency.16 In addition, only surgeons
with at least 10 patients meeting the aforementioned criteria
at 12- or 24-month follow-up were included for comparison.
Caterpillar plots were used to demonstrate surgeon-level
variation on postsurgical EPIC-26 scores and sexual recovery.
To examine the correlation between surgeon case volume and
sexual function outcomes, Pearson and Spearman correlation
coefficients were calculated for mean EPIC-26 sexual function
score and proportion of patients achieving sexual function
recovery, respectively. All statistical analyses were performed
using SAS version 9.4 (SAS Institute). Two-tailed P values
were considered statistically significant at P < .05.

Results

b

Race

Black

115 (8)

Sample Description

White

1197 (84)

Otherc

25 (2)

Unknown

89 (6)

A total of 1426 male patients with baseline and 24-month
EPIC-26 sexual domain scores were included in the current
analysis (Table 1). The median (IQR) age was 64 (58-68) years.
Regarding race and ethnicity, 115 patients (8%) were Black; 1197
(84%) were White; 25 (2%) were of another race or ethnicity,
including Asian, Native American, or Hawaiian/Pacific Islander, combined owing to low numbers; and there were 89
patients (6%) for whom race and ethnicity were unknown. The
median (IQR) BMI was 28 (26-32), and most (1146 [90%]) were
married, in a relationship, or dating. Of 1416 patients with Gleason grade group score data, 958 (68%) had Gleason grade group
1 or 2 prostate cancer. Most patients (1074) underwent bilateral nerve-sparing RP (75%).

Gleason grade group
1

310 (22)

2

648 (46)

3

252 (18)

4

118 (8)

5

88 (6)

Clinical stage
cT1

1054 (74)

cT2/3

371 (26)

Nerve sparing

EPIC-26 Sexual Domain Scores

None

209 (15)

Unilateral

143 (10)

Bilateral

1074 (75)

Radical prostatectomy type
Laparoscopic/robotic

1370 (96)

Open

56 (4)

Abbreviation: BMI, body mass index.

138

tate-specific antigen, Gleason score, and clinical T stage), and
nerve-sparing status at RP as predictors. All predictors were
selected prior to analysis, and the model included random intercepts for surgeons to account for within-surgeon associations. Adjusted odds ratios and 95% CIs were reported for each
predictor.

a

Calculated as weight in kilograms divided by height in meters squared.

b

Race and ethnicity data were collected by self-report.

c

Other race designation includes American Indian, Asian, and Native
Hawaiian/Pacific Islander, combined owing to low overall numbers.

Table 2 shows mean EPIC-26 sexual domain scores by
nerve-sparing type. The mean (SD) EPIC-26 sexual domain
score at baseline was 48 (31) for those who underwent no
nerve sparing, 62 (28) for those who underwent unilateral
nerve sparing, and 63 (29) for those who underwent bilateral nerve sparing (P < .001). At 3-month follow-up, mean
(SD) EPIC-26 sexual domain score was 17 (16) for those who
underwent no nerve sparing, 22 (19) for those who underwent unilateral nerve sparing, and 27 (24) for those who
underwent bilateral nerve sparing (P < .001). At 24-month
follow-up, the mean (SD) EPIC-26 sexual domain score was
23 (23) for those who underwent no nerve sparing, 30 (25)
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Table 2. EPIC-26 Sexual Domain Scores at Each Assessment Time by Nerve Sparing
Nerve sparing
Metric

None

Unilateral

Bilateral

P value

Baseline
Respondents, No.

842

569

3300

EPIC-26 score, mean (SD)

48 (31)

62 (28)

63 (29)

<.001

3 mo
Respondents, No.

581

429

2479

EPIC-26 score, mean (SD)

17 (16)

22 (19)

27 (24)

<.001

6 mo
Respondents, No.

513

359

2107

EPIC-26 score, mean (SD)

17 (16)

25 (21)

30.2 (25)

<.001

12 mo
Respondents, No.

448

297

1780

EPIC-26 score, mean (SD)

21 (19)

27.6 (23)

35 (28)

<.001

24 mo
Respondents, No.

209

143

1074

EPIC-26 score, mean (SD)

23 (23)

30.3 (25)

39 (28)

for those who underwent unilateral nerve sparing, and 39
(28) for those who underwent bilateral nerve sparing
(P < .001).

Sexual Function Recovery
At 24-month follow-up, 336 of 1426 patients (24%) of
patients recovered sexual function (ie, recovered 90% or
more of their individual baseline EPIC-26 score). Patients
who recovered sexual function had lower baseline EPIC-26
sexual domain scores (median [IQR] score: recovered, 59
[21-87]; unrecovered, 72 [44-87]; P < .001). Regarding Gleason grade groups, 1210 of 1416 patients (85%) who recovered
90% or more of sexual function were in in Gleason grade
groups 1, 2, and 3 and 206 of 1426 (15%) were in Gleason
grade groups 4 and 5.
Table 3 shows the multivariable model for sexual function recovery. BMI, age, Gleason score, and baseline EPIC-26
sexual domain score were associated with sexual function
recovery. Patients with gross obesity (BMI 35 or greater) had
less recovery than patients with normal weight (BMI less
than 25; odds ratio, 0.55; 95% CI, 0.33-0.93); lower odds of
recovery were also observed in older patients (odds ratio,
0.77; 95% CI, 0.69-0.85), patients with better baseline
sexual function (odds ratio 0.82; 95% CI, 0.78-0.87), and
those with Gleason grade group 5 (odds ratio, 0.49; 95% CI,
0.24-1.00).
Regarding margin status, 379 of 1426 patients (27%) in
the 24-month cohort had positive margins. Of these, 87
(23%) recovered sexual function at 24-month follow-up. Of
1047 patients with negative margins, 249 (24%) recovered
sexual function. Of 1074 patients who underwent bilateral
nerve sparing, 264 (25%) had positive margins. Of 143
patients who underwent unilateral or no nerve sparing, 36
(25%) and 79 (38%), respectively, had positive margins.
jamasurgery.com

<.001

Abbreviation: EPIC-26, 26-item
Expanded Prostate Cancer Index
Composite.

Surgeon-Level Analyses
At 12-month follow-up, 18 surgeons and 649 patients met
inclusion c riteria for the surgeon-level analyses. At
24-month follow-up, 12 surgeons and 408 patients met criteria. The eTable in the Supplement includes characteristics
of these patients. Figure 1 illustrates wide surgeon-level
variation in mean EPIC-26 sexual domain scores at 12- and
24-month follow-up. Figure 2 illustrates surgeon-level
variation in sexual function recovery at 12- and 24-month
follow-up for the select cohort of patients with favorable
baseline characteristics.
For EPIC-26 sexual domain, mean (SD) scores ranged
from 23 (4) to 69 (8) (P < .001) at 12-month follow-up across
18 surgeons and from 27 (3) to 64 (7) (P < .001) at 24-month
follow-up across 12 surgeons. The proportion of patients
achieving sexual function recovery ranged from 0 to 10
(0%) to 4 of 10 (40%) (median [IQR], 20.1 [6.3-26.7]) at 12
months follow-up across 18 surgeons and from 1 of 37 (3%)
to 7 of 16 (44%) (median [IQR], 27.1 [15.3-36.6]) at 24-month
follow-up across 12 surgeons. Among the 18 surgeons
included in the analysis, median (IQR; range) RP volume
was 42 (30-73; 15-133) cases per year. Among the 12 surgeons included for the 24-month analysis, median (IQR;
range) annual RP volume was 38 (31-55; 22-133) cases. At the
surgeon level, the Pearson correlation coefficient between
case volume and mean EPIC-26 sexual domain score was
0.05 (95% CI, −0.45 to 0.48) at 12-month follow-up and
0.08 (95% CI, −0.52 to 0.62) at 24-month follow-up. The
Spearman correlation coefficient between case volume and
the proportion of patients achieving sexual function recovery was 0.02 (95% CI, −0.45 to 0.48) at 12-month follow-up
and −0.16 (95% CI, −0.67 to 0.46) at 24-month follow-up.
For the 12- and 24-month cohorts, 90% of surgeons in the
12-month analyses had been in practice for more than 10 years
(Reprinted) JAMA Surgery February 2022 Volume 157, Number 2
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Table 3. Multivariable Model for Sexual Function Recovery
Variable

OR (95% CI)

BMIa
<25

1 [Reference]

25-<30

0.94 (0.65-1.36)

30-<35

0.84 (0.56-1.28)

≥35

0.55 (0.33-0.93)b

Racec
White

1 [Reference]

Black

0.92 (0.56-1.51)

Otherd

0.92 (0.34-2.50)

Unknown

0.83 (0.45-1.50)

No diabetes

1.43 (0.90-2.27)

Gleason grade group
1

1 [Reference]

2

1.27 (0.90-1.77)

3

0.85 (0.55-1.31)

4

0.72 (0.40-1.31)

5

0.49 (0.24-1.00)

Clinical stage
cT1 disease

1 [Reference]

cT2/3 disease

1.08 (0.79-1.49)

Nerve sparing
None

1 [Reference]

Bilateral

1.29 (0.84-2.00)

Unilateral

0.70 (0.38-1.29)

Age (per 5 y)

0.77 (0.69-0.85)b

PSA

0.85 (0.70-1.03)

Baseline EPIC-26 (per 10-point units)
Sexual domain score

0.82 (0.78-0.87)b

Urinary domain score

0.92 (0.83-1.02)

Radical prostatectomy type
Laparoscopic/robotic

1 [Reference]

Open

0.88 (0.40-1.92)

Abbreviations: BMI, body mass index; EPIC-26, 26-item Expanded Prostate
Cancer Index Composite; OR, odds ratio; PSA, prostate-specific antigen.
a

Calculated as weight in kilograms divided by height in meters squared.

b

P < .05.

c

Race and ethnicity data were collected by self-report.

d

Other race designation includes American Indian, Asian, and Native
Hawaiian/Pacific Islander, combined given low overall numbers.

and 72% were fellowship trained. For the surgeons included
in the 24-month analysis, 90% had been in practice for more
than 10 years, and 75% were fellowship trained. Percentages
are given in lieu of raw numbers to protect the privacy of the
surgeons.

Discussion
In this study, we reported patient- and surgeon-level variation
of EPIC-26 sexual domain scores and sexual function recov140

ery. We found that, at the patient-level, sexual function was recoverable. At 24-month follow-up, approximately 25% of patients recovered 90% or more of sexual function. We also found
that that surgeon characteristics were associated with sexual
function outcomes, a factor that may be associated with surgeon skill. Surgeon-level analyses in a select cohort with favorable characteristics demonstrated significant variation across
MUSIC surgeons at 12- and 24-month follow-up in both mean
EPIC-26 sexual domain scores and proportion of patients who
recovered sexual function. No significant correlation was observed between surgeon case volume and sexual function outcomes. As skill is a modifiable factor, improving surgical skill
may lead to better sexual function outcomes and, in turn, decrease decision regret and improve patient satisfaction. These
findings suggest that collaborative quality improvement may be
needed to effect change in sexual function outcomes.
Prior studies have demonstrated similar trends in patientreported sexual function outcomes following RP.4,5,18 The Prostate Cancer Outcomes Study 34 demonstrated that 79% of patients who underwent RP had erectile dysfunction at 2-year
follow-up and 56% were bothered by sexual dysfunction. Of
all patient-reported outcomes following RP, erectile dysfunction was the most prevalent and bothersome.4 In our
study, we also found that age, BMI, baseline sexual function,
and Gleason grade group were predictive of sexual function
recovery. The finding of age, BMI, and Gleason grade group as
predictive of recovery is consistent with the literature.19-21 Our
finding that patients with higher baseline sexual function had
less recovery of sexual function may be because a patient with
a high baseline EPIC-26 score has to recover more function to
reach a level within 10% of that baseline value; conversely, patients with lower baseline sexual function do not have as far
to go. Regardless of sexual function recovery at the patient
level, the association with surgeon-level characteristics presents an opportunity for improvement. Given the success of
improving care and outcomes within the collaborative process of MUSIC, a collaborative quality improvement process
could be considered in this context.
To our knowledge, this is the first study to methodically
examine surgeon variation in patient-reported sexual function outcomes following RP. In this study, we build on a prior
report of variation in patient-reported urinary outcomes in
MUSIC.22 This variation was not associated with volume and
was present even in a cohort of patients with favorable characteristics and good baseline function who underwent bilateral nerve sparing. The stratification of patients into a cohort
with favorable characteristics (bilateral nerve sparing and a
baseline EPIC-26 score of 73 or higher) in this study allowed
for an in-depth examination of outcomes associated with individual surgeons. Surgeon-level outcomes are a potential avenue for collaborative quality improvement. The use of EPIC-26
allowed for examination of not only erectile dysfunction but
also other sexual functions, including erectile frequency, erectile and sexual ability, climax, and bother. Our finding that
sexual function outcomes by surgeon were not directly proportional to case volume was an original finding, not described or investigated in the literature, to our knowledge. Case
volume and outcome associations explored in the literature
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Figure 1. Mean 26-Item Expanded Prostate Cancer Index Composite (EPIC-26) Sexual Domain Scores
at 12- and 24-Month Follow-up by Michigan Urological Surgery Improvement Collaborative (MUSIC) Surgeon
A Mean EPIC sexual score at 12 mo
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have primarily focused on perioperative outcomes, such as
length of stay, readmission rate, treatment effects, and cancer
control, not on sexual function outcomes.23,24 Traditionally,
the highest-volume surgeons serve as the source of instruction and refinement within the literature, meetings, and
social media platforms. Whether volume alone correlates
with higher quality and superior outcomes is a complex,
debated issue, as some low-volume surgeons with experience
also have superior outcomes.25 This study indicated that for
sexual function outcomes, case volume did not correlate with
sexual function outcomes (ie, the highest-volume surgeons
did not have the best sexual function outcomes). The
surgeon-level factors that impact functional outcomes are
likely multifactorial, encompassing experience, technique,
and approach, among others.
There is an opportunity for a paradigm shift in PROs, which
may enhance care quality and value. A shift from solely rejamasurgery.com

EPIC-26 sexual domain score was
summarized among patients with
good baseline function (defined as a
baseline score of 73 or higher) who
underwent bilateral nerve sparing. All
surgeons had at least 10 patients with
patient-reported outcomes data at
respective times (12 or 24 months).
Error bars indicate 95% CIs. P values
are based on a multivariable
mixed-effects regression model
controlling for patient characteristics.

porting to reporting for improvement is essential and may be
transformative.26 The wide use and adaptation of robotics for
prostatectomy has many benefits; one major benefit that may
be transformative for quality improvement is video recording and review. Video review can allow for peer review and peer
rating, which can establish a baseline and serve as a benchmark from which to improve. Peer rating of operative skill has
been demonstrated as an effective method to measure
proficiency.22,27 Given technical variations in robotic assisted prostatectomy, this may be a starting point to correlate
technique and outcomes.28,29 Nerve sparing, for example,
which is closely associated with erectile function, is done using
several variations in technique and energy use (eg, cold incision, pinpoint cautery, Weck clips, and bipolar).28 In addition, there are several methods of nerve sparing (eg, interfascial, intrafascial, extrafascial, and retrograde release).30,31 It is
unclear which approach may lead to the best outcomes. Once
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Figure 2. Proportion of Patients Achieving Sexual Function Recovery at 12- and 24-Month Follow-up
by Michigan Urological Surgery Improvement Collaborative (MUSIC) Surgeon
A Patients achieving recovery at 12 mo
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technique and outcome relationships are clarified, this can facilitate coaching for surgeons to improve patient-reported
outcomes.32 Moreover, video review and coaching may be a
critical step in identifying and establishing best practices.

Limitations
This study has limitations. First, we only evaluated practices in
the state of Michigan; however, the practices have diverse patient composition, practice size, and surgeons, including both
high- and low-volume surgeons. Second, we did not report specific data on surgeon experience, such as training and years of
experience. Despite this, we did limit our surgeon-level analysis to a case volume of 10 or more per year in a cohort of patients with favorable characteristics who underwent bilateral
nerve-sparing RP and had baseline EPIC-26 scores of 73 or higher.
142

The 26-item Expanded Prostate
Cancer Index Composite sexual
domain score was summarized
among patients with good baseline
function (defined as a baseline score
of 73 or higher) who underwent
bilateral nerve sparing. All surgeons
had at least 10 patients with
patient-reported outcomes data at
respective time points (12 or 24
months). Error bars indicate 95% CIs.
P values are based on multivariable
mixed-effects regression model
controlling for patient characteristics.

Third, our case volume–outcome analysis did not include all surgeons and was limited to surgeons with a case volume of 10 or
more per year. This was done because inclusion of lowervolume surgeons would potentially bias or attenuate the results. This threshold was established to create a reliable measure of the case volume–outcome association. Fourth, we did
not include erectile aid use in this study. While this data point
is collected in MUSIC, a high level of missingness for this variable limits its utility. However, we did observe that the rate of
erectile aid use across surgeons was unsubstantial and do not
expect that exclusion of erectile aid use in this analysis impacted our findings in a meaningful way.
These limitations notwithstanding, our findings have implications for patients, surgeons, and policy makers. By understanding factors associated with sexual recovery, patients
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can optimize BMI, which may improve their chances for a satisfying sexual recovery and engage them in the recovery process. These data may also give patients more realistic expectations for recovery and encompass not only the physiologic
return of erections but also the psychologic aspect of intimacy. Our findings are important for surgeons; collaborative
quality improvement using video review and coaching is crucial to ensure the best techniques are undertaken to achieve
optimal outcomes for patients undergoing nerve-sparing RP.
For policy makers and hospital leaders interested in valuebased payment reform and quality, this study demonstrates
that collecting standardized PROs, which has previously been
described as a limitation to incorporating PROs into valuebased payment initiatives,33 can be feasible on a large scale for
evaluation of health care delivery and quality.
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Conclusions
Of all patient-reported outcomes for RP, sexual function outcomes are among the most reported and the most detrimental to quality of life. Our study found wide variation in sexual
function recovery associated with both patient- and surgeonlevel characteristics. Surgeons have an opportunity to potentially improve outcomes through collaborative quality improvement. Counterintuitive and challenging to traditional
teaching, this study found no significant correlation between
surgeon volume and sexual function outcomes. In the quest
for a cure, we should not neglect patient-reported outcomes
(eg, sexual function) that patients care very deeply about and
that directly impact quality of life.
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Invited Commentary

Identifying Top Talent to Improve Prostatectomy Sexual Outcomes
Is the Juice Worth the Squeeze?
Jeffery Vehawn; Brock O’Neil, MD

Agochukwu-Mmonu and colleagues report surgeon-level variation in sexual function outcomes over a 2-year period among men
undergoing radical prostatectomy. In a selected group of patients with good baseline function, they show substantial variation in outcomes achieved. Some surgeons had up to 40% of
patients recover sexual function while others had none.1
The foundation of this study is remarkable. Through the
Michigan Urological Surgery Improvement Collaborative
(MUSIC), the authors examine the effects of individual
surgeons on sexual function
Related article page 136
and recover y. It remains
quite rare for surgeons to permit such detailed information
about outcomes tied to surgical skill to be compared to others.
This speaks to the incredible trust cultivated among members
of MUSIC and serves as a model for transformative surgical
collaborations. Nevertheless, the study also raises important
issues.
First, the authors report outcomes of a large proportion of
men with low-grade prostate cancer with almost a quarter having grade 1 disease.1 However, patients such as these who are
managed with active surveillance are likely to experience bet144

ter sexual function outcomes compared to those managed with
radical prostatectomy.2,3 Surgical improvements are important, but in this case, focusing on encouraging active surveillance in patients with low-risk cancer could have equal or
greater improvements in sexual function outcomes.
Second, the authors did not identify a correlation between surgical volume and sexual function. This contradicts
results of other larger studies examining the relationship between surgical volume and complications, quality of life, and
sexual function.4,5 It is possible that the inclusion criterion requiring surgeons to have operated on at least 10 men with good
baseline sexual function over a 5-year period obscured this previously observed phenomenon. That is, a volume-outcome relationship may not be observed among surgeons who are well
established on the learning curve.
Additionally, included surgeons accounted for fewer than
30% of patients with good baseline sexual function. This further raises questions about the generalizability of results and
feasibility of interventions aimed at improving surgical skills.
What about the other 70% of patients operated on by surgeons without a high enough volume? If a perfectly designed
and implemented intervention raised all surgeons to the level
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